# Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness

Researchers at University of Pittsburg have found that patients who consume sucralose regularly have a lower likelihood of benefiting from immunotherapy and having longer survival times. Sucralose is an artificial sweetener that is commonly used in a variety of diet products, such as Splenda. This research is the first to connect the dietary choices that people make to groundbreaking cancer treatments.

 It remains to be seen whether the results obtained in lab tests can also be obtained in clinical trials on humans. As it is, the animal model study is eye-opening and could give entities like Calidi Biotherapeutics Inc. (NYSE American: CLDI) a lot to ponder in…

 Read More>>

 About BioMedWire

 BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

 BMW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.BioMedWire.com

 Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

 BioMedWireSan Francisco, CAwww.BioMedWire.com415.949.5050 OfficeEditor@BioMedWire.com

 BioMedWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/bmw/study-finds-that-common-sweetener-could-compromise-cancer-treatment-effectiveness/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/sucralose-may-reduce-cancer-treatment-effectiveness-study-finds/9d973c62190a06829fad5c4e8ccdfc0c) 


Pickup - [https://burstable.news/news](https://burstable.news/news/202509/207492-study-links-sucralose-consumption-to-reduced-effectiveness-of-cancer-immunotherapy)

Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202509/207494-estudio-revela-que-el-edulcorante-sucralosa-podria-reducir-la-efectividad-de-la-inmunoterapia-contra-el-cancer)

Pickup - [https://platzennachrichten.de/nachrichten](https://platzennachrichten.de/nachrichten/202509/207588-studie-der-university-of-pittsburgh-sussstoff-sucralose-konnte-wirksamkeit-von-krebstherapien-beeintrachtigen)

Pickup - [https://actueclair.com](https://actueclair.com/202509/207572-une-etude-revele-que-le-sucralose-pourrait-compromettre-l-efficacite-des-traitements-contre-le-cancer)
 



[Reddit Post](https://www.reddit.com/r/HealthCareNewsInfo/comments/1nfac10/sucralose_may_reduce_cancer_treatment/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/259/12/odorVIo0.webp)